Sagimet Biosciences (SGMT) Research & Development (2022 - 2026)
Sagimet Biosciences (SGMT) reported Research & Development of $11.54 million for Q2 2026, up 59.1% from $7.25 million a year earlier and up 64.9% from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Research & Development (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Sagimet Biosciences' Research & Development came in at $34.99 million, down 29.2% year-over-year; for FY2025, it was $39.05 million, up 1.6% from FY2024.
- Research & Development has a three-year compound annual growth rate of 16.2% (FY2022 to FY2025).
- By year, Research & Development came in at $38.44 million in FY2024 (+94.4%), $19.78 million in FY2023 (-20.6%) and $24.92 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q1 2025.
- Year over year, Research & Development gained in five of the last eight quarters, with growth averaging 55.2%.
- The high point for year-over-year Research & Development in five years was Q1 2025 (growth of 191.6%); the low point was Q1 2026 (a decline of 54.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7 million (Q1 2026), $6.73 million (Q4 2025) and $9.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Sagimet Biosciences | 569.92 Mn | -4.57 Mn | - | 11.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.54 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 6.73 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Jun 30, 2025 | 7.25 Mn |
| Mar 31, 2025 | 15.34 Mn |
| Dec 31, 2024 | 14.22 Mn |
| Sep 30, 2024 | 12.65 Mn |
| Jun 30, 2024 | 6.31 Mn |
| Mar 31, 2024 | 5.26 Mn |
| Dec 31, 2023 | 5.66 Mn |
| Sep 30, 2023 | 4.96 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 4.49 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 6.84 Mn |
| Jun 30, 2022 | 6.37 Mn |
API Access
Sagimet Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();